According to Future Market Insights, the global market for catheter-associated urinary tract infections treatment is poised for steady growth over the next decade. With a projected compound annual growth rate (CAGR) of 3.0%, the market value is expected to rise from USD 1.31 billion in 2023 to USD 1.76 billion by 2033.
The market experienced a valuation of USD 1.26 billion at the end of 2022, and the upward trajectory is expected to continue with a Year-on-Year (Y-o-Y) growth of 3.9% in 2023. This growth is attributed to the rising incidence of catheter-associated infections and an increasing demand for effective treatments, driven by advancements in medical technology and healthcare infrastructure worldwide.
Key Market Drivers:
- Rising CAUTI Incidence: As healthcare facilities expand, the use of catheters for patient care also increases, leading to higher incidences of urinary tract infections (UTIs) associated with catheter use. This drives the demand for specialized treatments.
- Technological Advancements in Treatment Options: Ongoing innovation in antimicrobial catheters, along with advanced infection control protocols, is expected to enhance treatment outcomes and reduce the risk of infections.
- Increased Healthcare Spending: Growing healthcare investments globally, particularly in emerging economies, will further contribute to market growth by improving access to healthcare services and treatments.
The market’s expansion is also supported by an increasing awareness of infection prevention strategies and the ongoing development of infection management solutions tailored to the needs of patients with indwelling catheters.
Looking Forward:
With its strong growth prospects, the catheter-associated urinary tract infections treatment market offers significant opportunities for key players in the healthcare and pharmaceutical sectors to invest in cutting-edge solutions. As the global healthcare landscape continues to evolve, stakeholders are expected to benefit from advancements in treatment options, contributing to an overall reduction in infection-related healthcare costs.
Key Takeaways:
- Market Growth Forecast: The global catheter-associated urinary tract infections (CAUTI) treatment market is expected to grow steadily, with a projected compound annual growth rate (CAGR) of 3.0%. The market value is estimated to increase from USD 1.31 billion in 2023 to USD 1.76 billion by 2033.
- S. Market Outlook: The U.S. accounted for 18.2% of the global market share in 2022, with an expected CAGR of 2.2% during the forecast period. The increasing prevalence of chronic illnesses like diabetes, kidney disease, and bladder cancer, which require catheter usage, is a key driver of market growth in the U.S.
- Rising Complicated UTIs: The growing use of urinary catheters, especially indwelling catheters, has contributed to the rise in complicated urinary tract infections (UTIs). These infections are harder to treat and present a greater risk of complications, driving demand for treatment solutions.
- India’s Market Dominance: India held 10.2% of the global CAUTI treatment market share in 2022. With a large and growing patient population (1.42 billion people), the incidence of CAUTIs is high, fueling demand for effective treatments.
- China’s Efforts to Combat CAUTIs: China, with a market share of 9.5% in 2022, has implemented several government initiatives to reduce healthcare-associated infections, including CAUTIs. These efforts focus on raising awareness, training healthcare providers, and supporting infection prevention measures in healthcare settings, contributing to increased demand for CAUTI treatments.
Enhanced Interest in Market Trends: Access In-Depth Analysis and Insights with Our Full Report!
Competitive Landscape:
The catheter-associated urinary tract infection treatment market is highly competitive. Market leaders are focusing on enhancing their presence in emerging markets through strategic partnerships, mergers, and acquisitions, while also emphasizing the launch of innovative, technologically advanced products. The competitive environment is shaped by a combination of global and local players who hold a significant share of the market, with key activities including mergers, acquisitions, and collaborations with prominent market participants.
Notable developments include:
- In June 2019, Merck announced a definitive agreement with Tilos Therapeutics to co-develop drugs for the treatment of cancer, fibrosis, and autoimmune diseases.
- In November 2018, Allergan revealed that the FDA had accepted the Supplemental New Drug Application for Avycaz, aimed at treating patients with Complicated Urinary Tract Infections (CUTI) and Complicated Intra-Abdominal Infections (CIAI).
Key Companies Covered:
- Pfizer Inc.
- Merck & Co., Inc.
- GlaxoSmithKline (GSK)
- AstraZeneca
- Bayer AG
- Johnson & Johnson
- Novartis International AG
- Sanofi
- Roche Holding AG
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Abbott Laboratories
- Astellas Pharma Inc.
- Boehringer Ingelheim
- Daiichi Sankyo Company, Limited
Key Segments Covered in Urinary Tract Infections Treatment Industry Research:
Drug Type:
- Penicillin & Combinations
- Amoxicillin
- Amoxicillin+ Clavulanate Potassium
- Others
- Quinolones
- Ciprofloxacin
- Levofloxacin
- Nalidixic acid
- Norfloxacin
- Others
- Cephalosporin
- Ceftriaxone
- Cefuroxime
- Cefixime
- Cephalexin
- Aminoglycoside Antibiotics
- Amikacin
- Gentamicin
- Sulphonamides (Sulfamethoxazole +Trimethoprim)
- Azoles and Amphotericin B
- Tetracycline (Doxycycline)
- Nitrofurans (Nitrofurantoin)
- Other
Indication Type:
- Asymptomatic CAUTI (Bacteriuria)
- Symptomatic CAUTI (Bacteremic)
Distribution Channel:
- Hospital Pharmacies
- Gynaecology and Urology Clinics
- Drug Stores
- Retail Pharmacies
- Online Drug Stores
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube